Keywords
lemongrass
Cymbopogon citratus
antifungal activity
essential oil
How to Cite
Abstract
The antifungal activity of Cymbopogon citratus essential oil was assessed by means of agar diffusion technique on 24 Candida albicans isolates and 15 Candida tropicalis isolates originated from patients with suspected nosocomial infection, and one Candida albicans ATCC 10231 standard strain. Cymbopogon citratus essential oil showed antifungal activity on 100% of the isolates which were analyzed from 25% (v/v) on concentrations, indicating its effective activity on nosocomial microorganisms.
References
1. Mukherjee PK, Saritha GS, Suresh B. Antimicrobial potential of two different Hypericum species available in India. Phytother Res 2002; 16 (7): 692-5.
2. Jordà-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, León MA, et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007; 50 (4): 302-10.
3. Karaman I, Sahin F, Güllüce M, Ögütçü H, Sngül M, Adigüzel A. Antimicrobial activity of aqueous and methanol extracts of Juniperusoxycedrus L. J Ethnopharmacol 2003; 85 (2/3): 231-5.
4. Kung HC, Wang JL, Chang SC, Wang JT, Sun HY, Hsueh PR, et al. Community-onset candidemia at a university hospital, 1995-2005. J Microbiol Immunol Infect 2007; 40: 355-63.
5. Shen YZ, Qi TK, Ma JX, Jiang XY, Wang JR, Xu QN, et al. Invasive fungal infections among inpatients with acquired immune defi ciency syndrome at a Chinese university hospital. Mycoses 2007; 50: 475-80.
6. Xie GH, Fang XM, Fang Q, Wu XM, Jin YH, Wang JL, et al. Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients. Crit Care [serial online] 2008; 12 (1): Available from: URL: http://ccforum.com/content/12/1/R5
7. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, et al. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fl uconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 2001; 39 (9): 3254-9.
8. Bougnoux ME, Kac G, Aegerter P, D’enfert C, Fagon JY, Candirea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 2008; 34 (2): 292-9.
9. Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, et al. Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. Diagn Microbiol Infect Dis 2007; 59 (4): 407-14.
10. Lagrou K, Verhaegen J, Peetermans WE, De Rijdt T, Maertens J, Van Wijngaerden E. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis 2007; 26 (8): 541-7.
11. Odds FC, Hanson MF, Davidson AD, Jacobsen MD, Wright P, Whyte JA, et al. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol 2007; 56: 1066-75.
12. Colombo AL, Nucci M, Salomão R, Branchini MLM, Richtmann R, Derossi A, et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 1999; 34 (4): 281-6.
13. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006; 44 (8): 2816-23.
14. da Matta DA, De Almeida LP, Machado AM, Azevedo AC, Kusano EJ, Travassos NF, et al. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in São Paulo, Brazil, 1995–2003. Diagn Microbiol Infect Dis 2007; 57 (4): 399-404.
15. Lee JS, Shin JH, Lee K, Kim MN, Shin BM, Uh Y, et al. Species distribution and susceptibility to azole antifungals of Candidabloodstream isolates from eight university hospitals in Korea. Yonsei Med J 2007; 48 (5): 779-86.
16. Alves SH, Lopes JO, Cury AE. Teste de suscetibilidade aos antifúngicos. Por que, quando e como realizar. NewsLab 1997; 25: 140-8.
17. Trabulsi LR, Alterthum, F. Microbiologia. 4a ed. São Paulo, São Paulo: Atheneu; 2004.
18. Hazen KC, Baron EJ, Colombo AL, Girmenia C, Sanchez-Souza A, Palacio A, et al. Comparison of the susceptibilities of Candida spp. to fl uconazole and voriconazole in a 4-year global evaluation using disk diffusion. J Clin Microbiol 2003; 41 (12): 5623-32.
19. Lima EO, Farias NMP. Atividade antifúngica de óleos essenciais, obtidos de plantas medicinais, contra leveduras do gênero Candida. R Bras Ci Saúde 1999; 3(1/3): 51-64.
20. Castro LO, Ramos RLD. Principais gramíneas produtoras de óleos essenciais. Porto Alegre, Rio Grande do Sul: FEPAGRO; 2003.
21. Ortiz RS, Marrero GV, Navarro ALT. Instructivo técnico para el cultivo de Cymbopogon citratus (D.C.) Stapf (caña santa). Rev Cubana Plant Med 2002; 7 (2): 89-95.
22. Akisue G, Akisue MK, Silva RJ, Andaluz MI. Padronização da droga e do extrato fl uído de Cymbopogon citratus (DC) Stapf. Lecta 1996; 14 (2): 109-19.
23. Cortez LER, Jacomossi E, Cortez DAG. Levantamento das plantas medicinais utilizadas na medicina popular de Umuarama, PR. Arq Ciênc Saúde Unipar 1999; 3 (2): 97-104.
24. Mishra AK, Dubey NK. Evaluation of some essential oils for their toxicity against fungi causing deterioration of stored food commodities. Appl Environ Microbiol 1994; 60 (4): 1101-5.
25. Pontes ZBV. Atividade antifúngica de rodutos naturais e sintéticos sobre espécies de Trichosporon Behrend [Tese de doutorado]. João Pessoa, Paraíba: Universidade Federal da Paraíba, 2002. 189 pp.
26. Cimanga K, Kambu K, Tona L, Apers S, De Bruyne T, Hermans N, et al. Correlation between chemical composition and antibacterial activity of essential oils of some aromatic medicinal plants growing in the Democratic Republic of Congo. J Ethnopharmacol 2002; 79: 213-20.
27. Martins PM. Infl uência da temperatura e da velocidade do ar de secagem no teor e da composição química do óleo essencial de capim-limão (Cymbopogon citratus (D.C.) Stapf ) [Tese de Magister Scientiae]. Viçosa, Minas Gerais: Universidade Federal de Viçosa, 2000. 77 pp.
28. Fortes CC, Dalston RCR. Manual de química orgânica experimental. 1a ed. Brasília: Universa; 2003.
29. Adams RP. Identifi cation of essential oil components by Gas Chromatography/Mass Spectroscopy. 4 th ed. Illinois: Carol Stream; 1995.
30. Okeke MI, Iroegbu CV, Eze EN, Okoli AS, Esimone CO. Evaluation of extracts of the roots of Landolphia oweeunce for antibacterial activity. J Ethnopharmacol 2001; 78 (2/3): 119-27.
31. Cole MD. Key antifungal, antibacterial and anti-insect assays – a critical review. Biochem Syst Ecol 1994; 22 (8): 837-56.
32. Grove DC and Randall WA. Assay methods of antibiotics: a laboratory manual. New York: Medical Encyclopedia Inc; 1955.
33. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Pennsylvania: NCCLS; 2003.
34. Schuck VJA, Fratini M, Rauber CS, Henriques A, Schapoval EES. Avaliação da atividade antimicrobiana de Cymbopogon citratus. Rev Bras Ciên Farm 2001; 37 (1): 45-9.
35. Onawunmi GO. Evaluation of the antifungal activity of lemon grass oil. Int J Crude Drug Res 1989; 27 (2): 121-6.
36. Carmo CMF, Lima EO, Milan EP. Atividade antifúngica e extratos e óleos essenciais contra Candida albicans isolada de pacientes com AIDS. Rev Bras Farm 1998; 79 (3/4): 108-11.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2009 Instituto Adolfo Lutz Journal